Brought to you by

Eisai to acquire US biotech Morphotek for $325mm
02 Apr 2007
Executive Summary
Japan's fourth-largest drug maker Eisai Co. Ltd. will pay $325mm in cash to buy privately held US biotech Morphotek.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
-
Large Molecule
- Antibodies
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com